Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: A study in an Asian population

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 120 B, Issue 1, 2003, Pages 58-62

  Tan, E K ^a,b,c   Chai, A ^a   Lum, S Y ^a   Shen, H ^a   Tan, C ^a   Teoh, M L ^a   Yih, Y ^a   Wong, M C ^a,b   Zhao, Y ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c Singapore Health Services   (Singapore)

Author keywords

Monoamine oxidase B; Parkinson's disease; Polymorphism; Smoking

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;

ADULT; AGED; ALLELISM; ARTICLE; ASIAN; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DNA EXTRACTION; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MODULATION; ONSET AGE; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SINGAPORE;

GYMNOMYZA SAMOENSIS;

EID: 0042823846     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20035     Document Type: Article

References (23)

1. Bird TD, Jarvik GP, Wood NW. 2001. Genetic association studies: Genes in search of diseases. Neurology 57:1153-1154.
2. Checkoway H, Franklin GM, Costa-Mallen P, Smith-Weller T, Dilley J, Swanson PD, Costa LG. 1998. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology 50:1458-1461.
3. Costa P, Checkoway H, Levy D, Smith-Weller T, Franklin GM, Swanson PD, Costa LG. 1997. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet 74:154-156.
4. Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H. 2000. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry 69:535-537.
5. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R. 1996. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736.
6. Garpenstrand H, Ekblom J, Forslund K, Rylander G, Oreland L. 2000. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype, J Neural Transm 107:523-530.
7. Hernan MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A. 2001. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 50:780-786.
8. Hernan MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. 2002. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Neurology 58:1381-1387.
9. Ho SL, Kapadi AL, Ramsden DB, Williams AC. 1995. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 37:403-405.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
11. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. 1993. Association of a monoamine oxidase B allele with Parkinson's disease, Ann Neurol 33:368-372.
12. Langston JW. 1998. Epidemiology versus genetics in Parkinson's disease: Progress in resolving an age-old debate. Ann Neurol 44(3 Suppl 1):S45-S52.
13. Mellick GD, McCann SJ, Le Couter DG. 1999a. Parkinson's disease, MAOB, and smoking. Letter. Neurology 53:658.
14. Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG. 1999b. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 14:219-224.
15. Mellick GD, Buchanan DD, Silburn PA, Chan DK, Le Couteur DG, Law LK, Woo J, Pang CP. 2000. The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J Neurol 247:52-55.
16. Morimoto Y, Murayama N, Kuwano A, Kondo I, Yamashita Y, Mizuno Y. 1995. Association analysis of a polymorphism of the monoamine oxidase B gene with Parkinson's disease in a Japanese population. Am J Med Genet 60:570-572.
17. Nakatome M, Tun Z, Shimada S, Honda K. 1998. Detection and analysis of four polymorphic markers at the human monoamine oxidase (MAO) gene in Japanese controls and patients with Parkinson's disease. Biochem Biophys Res Commun 247:452-456.
18. Nanko S, Ueki A, Hattori M. 1996. No association between Parkinson's disease and monoamine oxidase A and B gene polymorphisms. Neurosci Lett 204:125-127.
19. Plante-Bordeneuve V, Taussig D, Thomas F, Said G, Wood NW, Marsden CD, Harding AE. 1997. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: Evidence for association of a DRD2 allele. Neurology 48:1589-1593.
20. Riederer P, Konradi C, Hebenstreit G, Youdim MB. 1998. Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand (Suppl) 126:41-45.
21. Tan EK, Khajavi M, Thornby JI, Nagamitsu S, Jankovic J, Ashizawa T. 2000. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 55;533-538.
22. Wu RM, Cheng CW, Chen KH, Lu SL, Shan DE, Ho YF, Chern HD. 2001. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Neurology 56:375-382.
23. Yong VW, Perry TL. 1986. Monoamine oxidase B, smoking, and Parkinson's disease. J Neurol Sci 72:265-272.